{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04774315",
            "orgStudyIdInfo": {
                "id": "18-0850"
            },
            "organization": {
                "fullName": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "briefTitle": "Molecular Endotypes of Chronic Idiopathic Urticaria",
            "officialTitle": "Molecular Endotypes of Chronic Idiopathic Urticaria",
            "therapeuticArea": [
                "Other"
            ],
            "study": "molecular-endotypes-of-chronic-idiopathic-urticaria"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-02-16",
            "studyFirstSubmitQcDate": "2021-02-26",
            "studyFirstPostDateStruct": {
                "date": "2021-03-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-03-23",
            "lastUpdatePostDateStruct": {
                "date": "2022-03-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Colorado, Denver",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study plans to learn more about why some people with Chronic Idiopathic Urticaria (CIU) respond to treatment with omalizumab (Xolair). It will test people before they receive treatment with omalizumab as part of standard of care, to see if there are differences in their blood and skin that can predict who responds to treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Urticaria, Idiopathic"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Omalizumab",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Omalizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Omalizumab",
                    "description": "omalizumab 300mg SQ every 4 weeks as part of standard of care",
                    "armGroupLabels": [
                        "Omalizumab"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Responders",
                    "description": "The number of participants who meet the definition of \"Responder\" to omalizumab. \"Responders\" are defined as having a UAS7 of 6 or less after 16 weeks of treatment.",
                    "timeFrame": "Week 16"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Baseline expression of innate immune markers",
                    "description": "Baseline expression of innate immune markers in peripheral blood between eventual responders and nonresponders to omalizumab. 5 significant markers will be reported. Results will be stratified between groups determined by the pre-specified arms and by the classification of participants as responders versus non-responders to omalizumab.",
                    "timeFrame": "Baseline"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* CIU as defined as frequent urticarial lesions for \u2265 6 weeks\n* Symptoms not controlled with standard dose antihistamines (loratadine 10mg daily, desloratadine 5mg daily, fexofenadine 180mg daily, cetirizine 10mg daily, or levocetirizine 5mg daily)\n* Planned initiation of treatment with omalizumab (Xolair) as part of standard of care for antihistamine-refractory urticaria\n\nExclusion Criteria:\n\n* Use of immunomodulatory drugs in the past 1 month prior to beginning the study\n* Use of systemic steroids in the past 1 month prior to beginning the study\n* Use of omalizumab in the past 3 months prior to beginning the study\n* Use of any investigational agent in the past 30 days\n* Untreated intercurrent illness\n* Severe Asthma\n* Primary diagnosis of flushing",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jenny Stitt, M.D.",
                    "role": "CONTACT",
                    "phone": "303-724-1111",
                    "email": "clinicalresearchsupportcenter@ucdenver.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jenny Stitt, M.D.",
                    "affiliation": "University of Colorado, Denver",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Anschutz",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jenny Stitt",
                            "role": "CONTACT",
                            "phone": "303-724-7205",
                            "email": "jenny.stitt@cuanschutz.edu"
                        },
                        {
                            "name": "Jenny Stitt, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014581",
                    "term": "Urticaria"
                },
                {
                    "id": "D000080223",
                    "term": "Chronic Urticaria"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017445",
                    "term": "Skin Diseases, Vascular"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17330",
                    "name": "Urticaria",
                    "asFound": "Urticaria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2129",
                    "name": "Chronic Urticaria",
                    "asFound": "Chronic Urticaria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19714",
                    "name": "Skin Diseases, Vascular",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069444",
                    "term": "Omalizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018926",
                    "term": "Anti-Allergic Agents"
                },
                {
                    "id": "D000018927",
                    "term": "Anti-Asthmatic Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M413",
                    "name": "Omalizumab",
                    "asFound": "Previously Treated",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20962",
                    "name": "Anti-Allergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20963",
                    "name": "Anti-Asthmatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AAll",
                    "name": "Anti-Allergic Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}